Hypothesis

Berberine’s unique inhibition of UHRF1 sustains AMPK phosphorylation and remodels the epigenetic landscape at telomeres, lowering the informational entropy of telomeric chromatin. This change reduces transcriptional noise that drives senescence in normal cells while concurrently suppressing TERT/TERC expression in cancer cells, explaining how berberine shortens telomeres in tumors yet extends lifespan in aging models.

Mechanistic Basis

Berberine activates lysosomal AMPK independently of PEN2 and blocks UHRF1‑mediated dephosphorylation of AMPK [1]. Persistent AMPK activity phosphorylates histone modifiers, promoting a more open chromatin state at subtelomeric regions. Open chromatin decreases the spread of repressive heterochromatin, which lowers the stochastic transcription of telomere‑associated repeat‑containing RNA (TERRA) and thus reduces the informational entropy of the telomere locus. In normal cells, lower TERRA noise attenuates the senescence‑associated secretory phenotype, extending healthspan [3]. In cancer cells, the same chromatin shift facilitates recruitment of repressive complexes to the TERT and TERC promoters, suppressing telomerase activity and triggering telomere attrition [2].

Testable Predictions

1. Chromatin state – Treating primary human fibroblasts with berberine will increase H3K9ac and decrease H3K9me3 at subtelomeric regions, measurable by ChIP‑qPCR, without altering telomere length (TRF assay).
2. TERRA levels – Berberine treatment will reduce TERRA transcripts in normal cells, correlating with reduced SASP cytokines

Hypothesis: Age‑associated loss of cystatin B removes a key brake on cysteine cathepsins, allowing their unchecked activity to promote lysosomal membrane damage and to catalyze the activation of leaked aspartyl cathepsin D, thereby intensifying inflammaging and neurodegeneration.

Mechanistic rationale Cystatin B is a potent endogenous inhibitor of cysteine cathepsins (B, L, H) that normally resides in the lysosomal lumen and cytosol. Recent work shows that lysosomal membrane permeabilization (LMP) during aging is driven by oxidative stress, iron overload, lipid peroxidation and lipofuscin, creating pores that leak cathepsins into the cytoplasm 1. In retinal pigment epithelial cells, iron overload impairs cathepsin D maturation and elevates the pro/mature ratio six‑fold 2. Cytosolic cathepsin B then activates NLRP3 inflammasomes in macrophages and microglia, driving IL‑1 release, mitochondrial dysfunction and pyroptosis 3. Broad autophagy‑lysosomal failure is a hallmark of neurodegenerative disease, with cathepsin dysregulation at its core 4.

Notably, the cystatin B–cysteine cathepsin axis is absent from these discussions. We propose that declining cystatin B with age lifts inhibition on cysteine cathepsins, which then:

1. Directly destabilize lysosomal membranes by cleaving lumenal glycoproteins o

Hypothesis

Indole-3-propionic acid (IPA) produced by gut tryptophan‑metabolizing bacteria activates the pregnane X receptor (PXR) in intestinal epithelium and distal tissues, thereby coordinating a transcriptional program that simultaneously mitigates genomic instability, mitochondrial dysfunction, proteostatic decline, cellular senescence, stem cell exhaustion, and dysbiosis. We propose that IPA‑PXR signaling functions as an upstream controller of the hallmarks of aging, positioning gut barrier integrity not as a late integrative hallmark but as a primary driver of systemic aging.

Mechanistic rationale

1. Barrier‑centric signaling – IPA‑PXR activation up‑regulates tight‑junction proteins (claudin‑1, occludin) and mucin synthesis via IL‑22‑dependent pathways, reducing endotoxin translocation and inflammaging [4]. Lower circulating LPS attenuates NF‑κB‑mediated DNA damage responses, directly limiting genomic instability.
2. Metabolic‑epigenetic coupling – PXR induces expression of NAD+ biosynthetic enzymes (Nampt) and sirtuin activators, boosting SIRT1/3 activity. Enhanced sirtuin deacetylase action promotes DNA repair, mitochondrial biogenesis (via PGC‑1α deacetylation), and autophagy flux, linking barrier integrity to mitochondrial dysfunction and proteostasis [2]
3. Senescence modulation – IPA‑PXR signaling suppresses p16^INK4a^ transcription through increased SIRT6‑dependent deacetylation of histone H3K9 at the Cdkn2a locus, thereby reducing senescent

Hypothesis

Mitochondrial ROS in vascular smooth muscle cells (VSMCs) triggers the release of exosomes enriched in miRNA-21, which drives senescent cells to upregulate elastases and thereby amplifies elastin fragmentation, elastokine production, and arterial calcification.

Mechanistic Rationale

Oxidative modification of tropoelastin blocks elastic fiber assembly and promotes self‑aggregation [1]. Degradation by upregulated elastases from senescent cells generates elastokines such as VGVAPG that activate NEU1‑dependent inflammation and VSMC osteogenic transdifferentiation [2]. While antioxidants can reduce oxidative TE modifications [1] and senolytics lower elastase activity [2], the upstream signal that links mitochondrial ROS to elastase induction remains unclear. We propose that VSMC‑derived mitochondrial ROS activates the redox‑sensitive transcription factor NF‑κB p65, which increases transcription of the miRNA‑21 host gene (MIR21HG). miRNA‑21 is packaged into exosomes via the sphingomyelinase pathway and released into the extracellular milieu. Exosomal miRNA‑21 is taken up by neighboring senescent fibroblasts and macrophages, where it suppresses PTEN and PDCD4, leading to heightened AKT signaling and a SASP that includes MMP‑12 and cathepsin K—key elastases. This creates a feed‑forward loop: more ROS → more exosomal miRNA‑21 → more elastase → more elastin fragments → more elastokine‑driven inflammation → more VSMC ROS production via NOX activation. The loop explains why targeting only one node (e.g., senolytics) yields partial relief, whereas combined attenuation

Hypothesis

Chronic mTOR inhibition does not simply mimic famine; it locks cells into a diapause‑like developmental arrest that conserves resources but prevents true tissue renewal. When this state is sustained, epigenetic drift accumulates and the modest 5‑10% lifespan extension observed with rapamycin reflects a trade‑off between survival and functional decline. Intermittent re‑activation of mTOR signaling—through brief, calibrated nutrient pulses—should reset the diapause program, clear epigenetic noise, and unlock the full rejuvenative potential seen with caloric restriction.

Mechanistic Basis

Rapamycin‑driven mTORC1 suppression robustly activates autophagy and stress‑defense pathways, a signature indistinguishable from the transcriptional response to embryonic diapause in many species (2). Diapause is characterized by global chromatin compaction, reduced RNA polymerase II pausing, and increased deposition of repressive histone marks, effectively pausing development while preserving viability. Recent work shows that prolonged autophagy without corresponding anabolic bursts leads to lysosomal exhaustion and impaired proteostasis (5). We propose that the same lysosomal wear‑out underlies the limited longevity benefit of rapamycin: cells survive longer but cannot rebuild youthful architecture because the diapause lock blocks the anabolic windows needed for tissue repair.

Caloric restriction, by contrast, generates rhythmic fluctuations in nutrient sensing—periods of lo

Hypothesis\nPF4 secreted by aged megakaryocytes binds CXCR3 on erythroid progenitors, activating Cdc42‑driven actin polymerization that enhances SOCS3 transcription, thereby dampening JAK2‑STAT5 signaling and causing EPO resistance. Neutralizing PF4 or inhibiting Cdc42 restores EPO sensitivity without exacerbating osteoclast activity.\n\n## Rationale\n- It's known that PF4 levels rise with age [2] and Cdc42 activity is elevated [3].\n- PF4 signaling through CXCR3 can activate Rho GTPases, leading to cytoskeletal changes that influence cytokine receptor trafficking.\n- SOCS3 is a known negative feedback regulator of EPO‑JAK2‑STAT5 signaling; its upregulation correlates with blunted erythropoiesis in inflammatory states.\n- Chronic inflammation (IL‑6, TNFα) already primes SOCS3 expression [1]; PF4 may add a synergistic signal via Cdc42.\n- High‑dose EPO can induce osteoclastogenesis [6]; targeting upstream PF4‑Cdc42‑SOCS3 axis may avoid this side effect.\n\n## Novel Mechanistic Insight\nWe propose that PF4‑CXCR3 engagement triggers a Cdc42‑dependent nucleation of actin filaments at the plasma membrane, facilitating the assembly of a signalosome that includes JAK2 and the transcription factor STAT3, which cooperatively drives SOCS3 gene expression. This actin‑dependent scaffold is absent in young progenitors, explaining their robust EPO response. In aged cells, excess actin stress fibers also impair mitochondrial positioning, increasing ROS and further stabilizing SOCS3 mRNA.\n\n## Testable Predictions\n1. Molecular – Aged human CD34+ erythroid progenitors will show hig

In obese, aged adipose tissue senescent adipocytes release extracellular vesicles enriched in FBLN7 mRNA and miR‑30a antagonists. These vesicles are preferentially taken up by PDGFRβ+ adipogenic stem and precursor cells (ASPCs), overriding TGF‑β/Smad2/3‑independent fibrotic programming and amplifying collagen I/VI deposition. Blocking exosome secretion or neutralizing vesicular FBLN7 restores ASPB adipogenic potential, reduces fibrosis, and improves metabolic health even when TGF‑β signaling remains active.

Mechanistic Rationale

The current model places FBLN7 as a cell‑autonomous profibrotic factor induced in PDGFRα+ ASPC2 by palmitate‑stressed adipocyte signals (see [1]). Aging, however, adds a layer of senescence‑associated secretory phenotype (SASP) that includes elevated extracellular vesicle (EV) release ([5]). We propose that senescent hypertrophic adipocytes load EVs with FBLN7 transcripts and with endogenous inhibitors of miR‑30a (a known antifibrotic miR that predicts metabolically healthy obesity ([4])). PDGFRβ+ ASPCs, a subset distinct from the PDGFRα+CD9high collagen‑producing progenitors ([2]), express high levels of EV uptake machinery (e.g., syndecan‑4) and, upon EV internalization, translate FBLN7 protein intracellularly. FBLN7 then acts as a scaffold that stabilizes latent TGF‑β complexes and simultaneously sequesters miR‑30a, creating a double‑hit: enhanced TGF‑β signaling and loss of miR‑30a‑mediated repression of COL1A1/ COL6A1 transcription. This mechanism can operate even when canonical TGF‑β ligands are neutralized, explaining why fibrosis persis

Hypothesis

Acarbose extends lifespan primarily in male mice by increasing colonic butyrate, which activates an androgen‑receptor‑dependent hepatic FGF21 signaling cascade that promotes autophagy and reduces inflammation; females lack sufficient androgen signaling to translate the butyrate signal into comparable FGF21 upregulation, explaining the observed sex dimorphism.

Mechanistic Model

1. Microbiome shift – Acarbose inhibition of α‑glucosidase delivers more resistant starch to the colon, enriching butyrate‑producing taxa (e.g., Lactobacillus, Bifidobacterium) and raising fecal butyrate【4†L1-L3】.
2. Butyrate signaling – Butyrate reaches the portal circulation, acts as a histone deacetylase inhibitor and activates GPR109A on enteroendocrine cells, stimulating secretion of GLP‑1 and peptide YY【6†L1-L2】.
3. Androgen receptor cross‑talk – In males, testicular androgen receptors (AR) are highly expressed in hepatocytes; butyrate‑induced HDAC inhibition increases AR transcriptional activity, leading to up‑regulation of the fibroblast growth factor 21 (Fgf21) gene【7†L1-L4】.
4. FGF21 effects – Hepatic FGF21 stimulates autophagy via AMPK‑ULK1 signaling, improves insulin sensitivity, and suppresses NF‑κB‑driven inflammation, collectively extending healthspan【3†L1-L3】.
5. Female limitation – Lower circulating testosterone and reduced hepatic AR expression blunt the butyrate‑AR‑FGF21 axis, so the same microbiome shift yields only modest metabolic improvement and a small lifespan gain.

Testable Predictions

• Prediction 1: Castrated male UM‑HET3 mi

Background\n\nRecent work shows that ambient light intensity as low as 200 lux suppresses melatonin onset and that darkness duration, not just wavelength, determines melatonin length and downstream metabolic effects [1]. Evening dim light impairs glucose homeostasis and suppresses hepatic clock genes, independent of sleep quality [3], 4] and [5]. These data indicate that the circadian system interprets the length of night as a metabolic cue.\n\n## Hypothesis\n\nWe propose that the suprachiasmatic nucleus (SCN) translates darkness duration into a tonic inhibitory signal to the liver via the splanchnic sympathetic nervous system, suppressing gluconeogenic gene expression (PEPCK, G6Pase) and hepatic glucose output. This pathway operates independently of melanopsin-mediated phototransduction and melatonin secretion; thus, actual darkness, not merely blue‑light filtration, is required for metabolic circadian gating.\n\n## Mechanistic Rationale\n\n1. The SCN receives light information through intrinsically photosensitive retinal ganglion cells (ipRGCs) but also integrates darkness duration via rebound activity of GABAergic neurons during the dark phase.\n2. During prolonged darkness, SCN GABAergic output to the paraventricular nucleus (PVN) reduces excitatory drive to sympathetic preganglionic neurons, lowering norepinephrine release onto hepatic sympathetic terminals.

Hypothesis

Senescent cells fail to generate the precise, transient autophagy pulse required for OSKM‑mediated reprogramming because constitutive SLC7A5‑mediated leucine uptake keeps mTORC1 active even under starvation conditions. We hypothesize that a combined, short‑lived inhibition of mTORC1 (with rapamycin) and of leucine import (with the SLC7A5 inhibitor BCH) delivered only during days 1‑3 of Yamanaka factor expression will re‑establish the autophagy pulse that drives metabolic reset without triggering oncogenic metabolism or cellular toxicity. In contrast, either rapamycin or BCH alone will not rescue autophagy flux or reprogramming efficiency in senescent cells.

Mechanistic Rationale

• Senescent metabolic lock: Senescent cells exhibit elevated SLC7A5 expression, leading to high intracellular leucine that sustains mTORC1 signaling irrespective of extracellular nutrient levels [5]. This blocks the ULK1‑dependent initiation of autophagy, preventing the timely dismantling of the differentiated proteome needed for pluripotency.
• Autophagy as a biosynthetic fuel: During successful reprogramming, autophagy provides amino acids for de‑novo protein synthesis that builds the pluripotency network [1][2]. The autophagy pulse must be transient; prolonged activation shifts metabolism toward a tumor‑like state [6] and impairs function [4].
• Temporal window: Rapamycin enhances iPSC formation when given at day 1 but inhibits it at day 3, indicating that autophagy must be active early and then subside [3]. A dual‑hit strategy that briefly lowers bo

Hypothesis

Declining nitric oxide (NO) bioavailability initiates a self‑amplifying mechanotransduction loop in vascular smooth muscle cells (VSMCs) via activation of the Hippo pathway effectors YAP/TAZ, which suppresses eNOS transcription and promotes a synthetic, matrix‑producing phenotype. This loop accelerates arterial stiffening and elevates pulse wave velocity (PWV) even when systemic blood pressure remains normal, making PWV an early readout of YAP/TAZ‑mediated vascular aging.

Mechanistic Rationale

1. NO loss → ↑ RhoA/ROCK activity – Reduced NO diminishes cGMP‑PKG signaling, releasing inhibition of RhoA. Active ROCK phosphorylates LATS1/2, impairing Hippo kinase activity and allowing nuclear translocation of YAP/TAZ[1].
2. YAP/TAZ nuclear signaling → ↓ eNOS, ↑ VSMC synthetic program – Nuclear YAP/TAZ binds TEAD transcription factors to repress NOS3 promoter activity and upregulate genes such as CTGF, FN1, and MMP9, fostering extracellular matrix deposition and VSMC dedifferentiation[2].
3. Matrix stiffening → impaired endothelial shear sensing – Increased collagen cross‑linking and elastin fragmentation raise local tissue stiffness, attenuating endothelial mechanotransduction of shear stress and further lowering eNOS activation[3].
4. Feedback to NO – YAP/TAZ also induces expression of asymmetric dimethylarginine (ADMA) via upregulated PRMT1, directly inhibiting eNOS and completing the cycle[4].
5. Modulation by GLP‑1RA – GLP‑1 receptor activation raises cAMP, activating PKA which phosphorylates YAP at Ser127, promoting cytoplasmic retention

Hypothesis

Chronic low-grade inflammation elevates replication stress in hematopoietic stem cells, increasing the rate of mosaic chromosomal alterations (mCAs). In individuals with efficient replication-fork protection and homologous recombination repair—enriched in centenarians—this stress is resolved without fixing errors, leading to lower mCA burden despite advanced age.

Mechanistic Basis

• Inflammatory cytokines (e.g., IL-6, TNF-α) activate CDK-dependent origin firing, causing fork stalling and DNA double-strand breaks that seed mCAs{[1]}{[2]}.
• Persons with high DNA-repair capacity (elevated BLM helicase, RAD51 activity) can restart forks or engage error-free repair, limiting fixation of breaks as mCAs{[5]}.
• Protective CNVRs at 7p11.2 and 19p12 observed in centenarians overlap telomere-maintenance genes (TERT, TERC) and shelterin components, potentially buffering telomere-associated fork stress{[4]}.
• Clone size correlates with total mutation burden because inflammation-driven stress amplifies the impact of each driver mutation, making expansion a function of both mutation number and inflammatory milieu{[5]}.

Testable Predictions

1. Plasma IL-6 levels will positively predict the yearly accrual rate of autosomal mCAs in longitudinal blood samples, independent of age and APOE ε4 status.
2. Centenarians will show lower γH2AX foci and higher RAD51 foci in circulating hematopoietic progenitors compared with age-matched controls, indicating reduced replication stress and enhanced homologous recombination.
3. CRISPR-mediated overexpression of BLM in human CD34+

Hypothesis

Circadian amplitude attenuation predicts mortality risk by disrupting the rhythmic autophagy‑lysosome flux that normally gates proteostatic repair during the rest phase. When circadian amplitude falls below a critical threshold, the phase‑locked activation of lysosomal hydrolases becomes arrhythmic, leading to chronic accumulation of damaged macromolecules and accelerated biological aging.

Mechanistic Insight

The core clock drives not only transcription of autophagy genes (e.g., LC3, ATG5) but also the rhythmic expression of lysosomal v‑ATPase subunits and cathepsins, creating a temporal gating mechanism that aligns autophagosome formation with lysosomal degradation capacity. This coupling ensures that cytosolic waste is cleared efficiently during the subjective night. Age‑related decline in BMAL1/CLOCK activity reduces the amplitude of both arms, uncoupling autophagosome formation from lysosomal readiness. The resulting "autophagic bottleneck" increases cytosolic p62/SQSTM1, elevates inflammasome activation, and drives systemic inflammation—a known mortality predictor.

Testable Predictions

1. In human peripheral blood mononuclear cells (PBMCs) collected every 4 h over 24 h, individuals with low circadian amplitude (measured by PER2::LUC bioluminescence or serum cortisol rhythm) will show a blunted LC3‑II/LLC‑I ratio peak and a concomitant rise in basal p62 levels compared with high‑amplitude counterparts.
2. Longitudinally, baseline circadian amplitude will inversely correlate with all‑cause mortality over 5 years, independent of age, sex, and c

Hypothesis

Crocetin does not act uniformly on HIF‑1α across brain cells; instead it creates a bistable response where HIF‑1α protein is decreased in astrocytes but increased in neurons under hypoxic stress. This cell‑type‑specific modulation arises from crocetin’s differential interaction with prolyl hydroxylase domain (PHD) enzymes, which is governed by the distinct labile iron pools and redox environments of astrocytes versus neurons. Consequently, astrocytic HIF‑1α suppression reduces glycolytic flux and lactate export, while neuronal HIF‑1α activation enhances oxidative metabolism and lactate‑dependent signaling, together improving neuronal bioenergetics and survival.

Mechanistic Rationale

Crocetin is a polyene dicarboxylic acid capable of chelating Fe²⁺, a cofactor required for PHD activity. In astrocytes, the basal labile iron pool is relatively high, and crocetin‑Fe²⁺ complexes preferentially inhibit PHD2, leading to HIF‑1α hydroxylation failure paradoxically resulting in increased VHL‑mediated degradation due to conformational changes that expose the degron (as observed in the ~46 % HIF‑1α drop in aged astrocytes) [1][2]. Neurons maintain a lower labile iron concentration and higher glutathione levels; here crocetin preferentially binds to the Fe²⁺ site of PHD3, stabilising its inactive conformation without promoting VHL recruitment, thereby allowing HIF‑1α accumulation and transcriptional activation of glycolytic and angiogenic genes. This divergent en

Hypothesis

We propose that giving somatic cells a germline‑grade editing budget requires two coupled actions: (1) a transient, BMP4‑induced epigenetic reset that erases age‑associated marks while preserving repressive H3K9me3 at young transposons, and (2) concurrent upregulation of telomerase (TERT) to stabilize chromosome ends. Together, these manipulations create a competitive bottleneck in which cells bearing high DNA damage or epigenetic noise are eliminated via apoptosis or senescence, leaving a rejuvenated, low‑damage pool.

Mechanistic Rationale

Germline immortality stems not from superior repair but from relentless culling of defective lineages at each reproductive bottleneck [1]. Primordial germ cells achieve a hypomethylated yet stable genome by retaining SETDB1‑mediated H3K9me3 on young transposable elements, preventing mutagenic activation [2]. Somatic cells discard telomerase and extensive epigenome remodeling, accepting damage accumulation under the disposable soma theory [[3](https://bio.libretexts.org/Bookshelves/Introductory_and_General_Biology/Biology_(Kimball]]. However, constitutive TERT expression extends somatic replicative capacity [4], and modulating SETDB1 in embryonic stem cells can mimic germline hypomethylation [2]. Moreover, BMP signaling can induce germline‑like reprogramming in vitro from pluri

Hypothesis

Germline cells sustain telomere length and epigenetic youth through constitutive TERT expression, specialized telomere‑directed base excision repair, and intergenerational reprogramming. Somatic B cells lack these safeguards, causing telomere attrition, oxidative telomere damage, and accumulation of age‑associated epigenetic marks that together curtail activation‑induced deaminase (AID)–driven somatic hypermutation (SHM) in germinal centers. We propose that transiently imparting germline‑grade telomere maintenance and epigenetic reset to aging B cells will restore their mutagenic capacity and preserve repertoire diversity.

Mechanistic basis

1. Telomerase boost – Inducible TERT expression (e.g., via a tamoxifen‑responsive ERT2‑TERT construct) in germinal center B cells will counteract replicative telomere shortening that limits proliferative cycles 2.
2. Telomere‑specific BER enhancement – Overexpressing telomere‑binding proteins such as TRF2 or supplementing with a telomere‑targeted antioxidant (e.g., MitoTEMPO conjugated to a telomere‑binding peptide) will shelter G‑rich repeats from oxidative lesions, mirroring germline shelterin‑regulated repair 3.
3. Epigenetic reset – Short‑term exposure to vitamin C (a Tet‑dependent demethylase cofactor) combined with a low‑dose HDAC inhibitor (e.g., entinostat) will erase age‑associated methylation marks and reactivate the TERT promoter, replicating the germline reprogramming wave [4](https://pmc.

Hypothesis

Core claim: In renal cells, the X‑linked histone demethylase KDM6A (UTX), which escapes X‑inactivation, is expressed at higher effective dosage in females (XX) than males (XY). This dosage difference leads to stronger demethylation of H3K27me3 at the promoters of CDKN2A (p16INK4a) and CDKN1A (p21), thereby restraining their transcription and delaying nephron senescence. Consequently, the female survival advantage in kidney ageing is, at least partly, a direct epigenetic consequence of X‑chromosome gene dosage rather than solely hormonal effects.

Mechanistic rationale

• KDM6A removes the repressive H3K27me3 mark, a modification known to keep CDKN2A/CDKN1A promoters poised for activation during stress‑induced senescence ([4]).
• Escape from X‑inactivation yields ~1.5‑fold higher KDM6A transcript levels in female kidney cortical tubules and glomeruli (inferred from GTEx X‑chromosome escape data) ([5]).
• Increased KDM6A activity would lower H3K27me3 occupancy at CDKN2A/CDKN1A, reducing p16/p21 transcription and thus attenuating the SASP, fibrosis, and tubular apoptosis that drive CKD progression ([2][3]).
• Males, with a single KDM6A allele, maintain higher basal H3K27me3 at these loci, making them more susceptible to senescence triggers such as angiotensin II or ischemic injury.

Testable predictions

1. Allele‑specific expression – In human kidney biopsies, females will show significantly higher KDM6A mRNA (and protein) levels than males after adjusting for age and eGFR; this difference will correlate inversely with CDKN2A/CDKN1A expression (RNA

Hypothesis

Telomere length in c-Kit⁺ cardiac progenitor cells (CPCs) does not merely count divisions; it integrates the heterogeneous burden of molecular damage—oxidative lesions, AGEs, mitochondrial mutations—into a single metric that reflects the informational entropy of the cell’s stress landscape.

Rationale

Recent work shows telomere attrition in cardiomyocytes can arise independently of replication via oxidative stress and telomeric protein loss [1, 2]. In low‑proliferative CPCs, this damage‑driven shortening correlates with senescence and loss of regenerative capacity. If telomeres act as a sensor that sums diverse insults, then cells with identical division histories but different damage profiles should display divergent telomere lengths that parallel the heterogeneity of their molecular damage.

We propose to quantify this heterogeneity using Shannon entropy applied to single‑cell multi‑omics data (transcriptome, proteome, and metabolome) and test whether telomere length predicts entropy scores across individual CPCs.

Experimental Design

1. Isolate c-Kit⁺ CPCs from young and aged mouse hearts; culture subsets under (a) low‑serum, hypoxic conditions to minimize replication, (b) oxidative stress (H₂O₂) to induce damage without division, and (c) proliferative stimulation (FGF2 + IGF2) to increase division count.
2. Measure telomere length per cell using quantitative fluorescence in situ hybridization (Q‑FISH) combined with flow‑FISH to obtain single‑cell t

Hypothesis

Aged human hearts accumulate senescent c‑Kit+ cardiac progenitor cells (CPCs) whose mitochondrial NAD+ depletion stabilizes HIF‑1α, amplifying NLRP3 inflammasome activity and skewing the senescence‑associated secretory phenotype (SASP) toward IL‑1β dominance. This IL‑1β‑rich SASP is packaged into exosomes enriched for miR‑34a, which are transferred to neighboring cardiomyocytes and endothelial cells, suppressing their proliferative capacity and perpetuating a regenerative block.

Mechanistic Basis

• NAD+ decline and HIF‑1α: In aging hematopoietic stem cells, NAD+ loss impairs SIRT3 activity, leading to mitochondrial ROS accumulation [2]. A parallel drop in NAD+ within cardiac c‑Kit+ CPCs would reduce SIRT3 deacetylation of HIF‑1α, allowing its stabilization even under normoxia. HIF‑1α transcriptionally upregulates NLRP3 and pro‑IL‑1β, biasing the SASP toward IL‑1β secretion.
• IL‑1β‑centric SASP: While SASP is heterogeneous, IL‑1β exerts potent paracrine senescence induction and inhibits cardiomyocyte cell‑cycle re‑entry via p21^CIP1^ upregulation [1]. An IL‑1β‑skewed secretome would therefore be more deleterious than a mixed SASP.
• Exosomal miR‑34a shuttling: IL‑1β signaling activates NF‑κB, which transcriptionally induces miR‑34a. Senescent CPCs load miR‑34a into exosomes via hnRNPA2B1‑dependent sorting. Exosome uptake by cardiomyocytes represses SIRT1 and cyclin D1, impairing proliferation and promoting fibrosis.
• Feedback loop: miR‑34a–mediated SIRT1 loss further elevates ROS and NAD+ consumption, deepening the metabolic defect in neig